Regulation of TP53 activity associated with correlation-enhancing genes in tumor that comprised CHD3 and CHD4–chromodomain-helicase-DNA–binding proteins (Figure 6B) was previously shown to downregulate TP53 levels by suppressing TP53 acetylation (Hirota et al., 2019). This evidence concerns the gene CHD3 and neoplasm.